0001192482-21-000642.txt : 20210805
0001192482-21-000642.hdr.sgml : 20210805
20210805172140
ACCESSION NUMBER: 0001192482-21-000642
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210803
FILED AS OF DATE: 20210805
DATE AS OF CHANGE: 20210805
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MOCH KENNETH I
CENTRAL INDEX KEY: 0001070009
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37526
FILM NUMBER: 211149584
MAIL ADDRESS:
STREET 1: 68 WILLOW AVE
CITY: LARCHMONT
STATE: NY
ZIP: 10538
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zynerba Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001621443
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 260389433
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 80 W. LANCASTER AVENUE
STREET 2: SUITE 300
CITY: DEVON
STATE: PA
ZIP: 19333
BUSINESS PHONE: 484-581-7505
MAIL ADDRESS:
STREET 1: 80 W. LANCASTER AVENUE
STREET 2: SUITE 300
CITY: DEVON
STATE: PA
ZIP: 19333
FORMER COMPANY:
FORMER CONFORMED NAME: Zynerba Pharmeceuticals, Inc.
DATE OF NAME CHANGE: 20141003
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2021-08-03
0001621443
Zynerba Pharmaceuticals, Inc.
ZYNE
0001070009
MOCH KENNETH I
C/O ZYNERBA PHARMACEUTICALS, INC.
80 W. LANCASTER AVENUE, SUITE 300
DEVON
PA
19333
1
0
0
0
Common Stock
2021-08-03
4
A
0
5000
0
A
5000
D
Stock Option (right to buy)
4.44
2021-08-03
4
A
0
7500
0
A
2031-08-03
Common Stock
7500
7500
D
The restricted stock award vests in full upon the earlier of (i) August 3, 2022, or (ii) the day before the Company's 2022 annual meeting of stockholders.
The option vests in full upon the earlier of (i) August 3, 2022, or (ii) the day before the Company's 2022 annual meeting of stockholders.
/s/ Suzanne M. Hanlon, Attorney-in-Fact
2021-08-05